ESG risks facing biopharmaceutical firms
Pricing, product governance and legal liabilities are some of the factors to consider when assessing drug companies.
The U.S. is the single most important country for examining the affordability of prescription drugs, as it accounted for about 40% of sales in the $1.4 trillion global prescription drug market as of 2021, according to research from Morningstar.
Very few people know the exact net prices any buyer
Learn more about reprints and licensing for this article.
